Investors are pouring money into emerging technologies, reminiscent of the autonomous vehicle boom, but many companies struggle with viable business models. The conversation shifts to a promising health tech startup, Cynics Medical, which aims to revolutionize glucose testing with a non-invasive device that could eventually perform comprehensive blood tests. The founder's ambitions reflect a growing obsession in Silicon Valley with longevity and health innovation.
